Envoy Medical (COCH) Earnings Analysis

Envoy Medical (COCH) next reports earnings on 2026-07-30, consensus EPS -0.09 USD. Last quarter (2026-05-11) it beat with EPS -0.11 USD vs -0.14 USD est (+21.4%). It has beaten estimates in 2/7 recent quarters (29%). Trailing P/E -0.68.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does COCH next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate-0.09 USD
Revenue estimate0.00B

COCH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-11-0.11 USD-0.14 USD+21.4%Beat
2026-03-23-0.26 USD-0.24 USD-8.3%Miss
2025-11-10-0.35 USD-0.27 USD-29.6%Miss
2025-07-31-0.32 USD-0.29 USD-10.3%Miss
2025-05-01-0.29 USD-0.35 USD+17.1%Beat
2024-11-14-0.37 USD-0.27 USD-37%Miss
2024-08-12-0.27 USD-0.24 USD-12.5%Miss

Beat rate: 2/7 (29%) over reported quarters with consensus data.

COCH valuation and analyst view

Trailing P/E-0.68
Trailing EPS-0.33523 USD
Price / book4.53
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Envoy Medical (COCH)'s next earnings date?

Envoy Medical is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.09 USD and revenue estimate of 0.00B.

Did COCH beat earnings last quarter?

In its 2026-05-11 report, COCH posted EPS of -0.11 USD versus a -0.14 USD estimate — a beat of 21.4%.

What is COCH's earnings track record?

Over the last 7 reported quarters with consensus data, COCH beat estimates 2 times (29%).

What is COCH's current P/E ratio and EPS?

COCH trades at a trailing P/E of -0.68 on trailing EPS of -0.33522903328006576 USD.

What do analysts rate COCH?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).